Pfizer Opts In To LianBio Rights to Respiratory Syncytial Virus Candidate In Greater China
Pfizer Inc (NYSE:PFE) has opted into the right to develop and commercialize LianBio’s (NASDAQ:LIAN) sisunatovir, a respiratory syncytial virus (RSV) therapeutic…